Syntel, Inc. (SYNT) Tops Q2 EPS by 4c, Beats on Revenues; Offers Positive FY17 EPS/Revenue Guidance

Syntel, Inc. (NASDAQ: SYNT) reported Q2 EPS of $0.44, $0.04 better than the analyst estimate of $0.40. Revenue for the quarter came in at $226.8 million versus the consensus estimate of $219.86 million.

Highlights:

• Q2 revenue of $226.8M, down 8% from year-ago quarter and up 0.4% sequentially
• Q2 EPS of $0.44 per diluted share, down 37% from year-ago quarter and 5% sequentially
• Q2 cash & short term investments of $87M
• Global Headcount of 21,850 on June 30, 2017, versus 23,773 in the year-ago quarter

GUIDANCE:

Syntel, Inc. sees FY2017 EPS of $1.62-$1.77, versus the consensus of $1.68. Syntel, Inc. sees FY2017 revenue of $865-900 million, versus the consensus of $872.9 million.

2017 Guidance

Based on current visibility levels and an exchange rate assumption of 64.5 Indian rupees to the dollar, the Company currently expects 2017 revenue of $865 million to $900 million and EPS in the range of $1.62 to $1.77.

For earnings history and earnings-related data on Syntel, Inc. (SYNT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c